Ochrobactrum anthropi

Background

Microbiology

• Oxidase positive, non-fermenting, Gram-negative bacillus

Management

• Essentially an ESBL, with resistance to cephalosporins and beta lactam-beta lactamase combinations, as well as aztreonam and ceftazidime
• Susceptible to gentamicin, amikacin, imipenem, ceftriaxone, and cefoperazone